Filmmaker Liz Canner takes a job editing erotic videos for a drug trial for a pharmaceutical company. Her employer is developing what they hope will be the first Viagra drug for women that wins FDA approval to treat a new disease: Female Sexual Dysfunction (FSD). Liz gains permission to film the company for her own documentary. Initially, she plans to create a movie about science and pleasure but she soon begins to suspect that her employer, along with a cadre of other medical companies, might be trying to take advantage of women (and potentially endanger their health) in pursuit of billion dollar profits. Orgasm Inc. is a look inside the medical industry and the marketing campaigns that are literally and figuratively reshaping our everyday lives around health, illness, desire—and that ultimate moment: orgasm.
Latest Ranking on Cumulative Box Office Lists
|All Time Domestic Box Office (Rank 12,001-12,100)
|All Time Worldwide Box Office (Rank 15,901-16,000)
|All Time Domestic Highest Grossing Limited Release Movies (Rank 4,701-4,800)
See the Box Office tab (Domestic) and International tab (International and Worldwide) for more Cumulative Box Office Records.
||February 11th, 2011 (Limited) by First Run Features, released as Orgasm Inc|
||Create your own comparison chart…|
||Medical and Hospitals, Corporate Malfeasance, Directing Yourself, Voiceover/Narration, Pharmaceuticals, Epilogue, Intertitle, Study of Sexuality|
|Source:||Based on Real Life Events|
|Production Method:||Live Action|
||Chicken and Egg Pictures, Astrea Media|
For a description of the different acting role types we use to categorize acting perfomances, see our Glossary.
Production and Technical Credits
The bold credits above the line are the "above-the-line" credits, the other the "below-the-line" credits.
July 25th, 2011
Summer time at the box office is amazing. From the first weekend in May until sometime in August, there is usually an average of one $100 million dollar movie released per week. This year will have at least three months in a row with at least one $100 million film. On the home market, on the other hand, summer time is crappy. This year has been particularly tiresome, as the spring wasn't a fun time at the box office. The biggest release this week is Source Code, which was only a midlevel hit. To be fair, it is one of the best-reviewed wide releases of the year. On the other hand, neither the DVD nor the Blu-ray are exactly overloaded with extras.
July 22nd, 2011
opened earlier in the year and did quite well on the per theater chart, especially for a documentary
, but the following week it collapsed. It did have a sensationalistic subject and perhaps its opening weekend was the result of hype more than anything else. Or did the subject matter make it more difficult for the film to expand?
June 21st, 2011
It's another busy week for DVD / Blu-ray with four first-run releases coming out this week. Five if you include Cedar Rapids, which was had surprisingly brisk ticket sales in limited release. Cedar Rapids is also the only one of the big releases that I would consider for Pick of the Week honors. Despite the number of wide releases on this week's list, I'm going with an unorthodox choice for Pick of the Week, "Weird Al" Yankovic - Alpocalypse, but Louie: Season One on Blu-ray earns an honorable mention.
February 15th, 2011
Strong reviews and an impressive cast helped Cedar Rapids top the per theater chart with an average of $20,198 in 15 theaters. Vidal Sassoon: The Movie was the only other film to reach an average of $10,000 with $13,053 in its lone theater.
February 11th, 2011
For the past several weeks, the Oscars have scared off a lot of competition for art house crowds. However, this week not only do we have Oscar Shorts opening, there are several films earning award-worthy reviews. My only concern is that there are so many strong choices, some of them will fall between the cracks and won't find the audience they deserve.
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue
are available through our research services. For more information, please contact us at firstname.lastname@example.org.